Ignite Creation Date:
2025-12-24 @ 7:22 PM
Ignite Modification Date:
2025-12-25 @ 5:01 PM
Study NCT ID:
NCT03565003
Status:
COMPLETED
Last Update Posted:
2024-09-25
First Post:
2018-05-29
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China
Sponsor:
Jacobio Pharmaceuticals Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-11-20
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-31
Completion Date Type:
ACTUAL
First Submit Date:
2018-05-29
First Submit QC Date:
None
Study First Post Date:
2018-06-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-23
Last Update Post Date:
2024-09-25
Last Update Post Date Type:
ACTUAL